HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shlomo Flechter Selected Research

Vaccines

1/2021COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shlomo Flechter Research Topics

Disease

10Multiple Sclerosis
11/2022 - 01/2002
6COVID-19
05/2022 - 01/2021
2Relapsing-Remitting Multiple Sclerosis
08/2015 - 06/2011
1Headache (Headaches)
01/2021
1Pain (Aches)
01/2021
1Fatigue
01/2021
1Frailty
08/2015
1Disease Susceptibility (Diathesis)
06/2011
1Disease Progression
06/2007
1Cognitive Dysfunction
06/2007

Drug/Important Bio-Agent (IBA)

3BNT162 VaccineIBA
05/2022 - 01/2021
3Immunoglobulin G (IgG)IBA
05/2022 - 12/2021
2CladribineFDA LinkGeneric
11/2022 - 01/2021
2Fingolimod Hydrochloride (FTY720)FDA Link
05/2022 - 01/2021
2COVID-19 VaccinesIBA
05/2022 - 01/2021
2mRNA VaccinesIBA
01/2021 - 01/2021
2Glatiramer Acetate (Copaxone)FDA Link
08/2015 - 01/2002
1VaccinesIBA
01/2021
1ocrelizumabIBA
01/2021
1Immunologic Factors (Immunomodulators)IBA
08/2015
1Interferon-betaIBA
08/2015
1InterferonsIBA
06/2011
1Therapeutic UsesIBA
06/2007
1Interferon beta-1b (Betaseron)FDA Link
06/2007

Therapy/Procedure

4Therapeutics
01/2021 - 06/2007
1Immunomodulation
03/2017
1Injections
08/2015